Aesthetic Medical Solution
  • COVID-19 Info
  • Amnio2X
  • About
  • Contact Us
  • ENDYMED RF
  • HD-PRP
  • CC1000 Cell Isolation Platform
  • Aesthetic Rejuvenation
  • DermaSweep 2.0
  • Regenerative Medicine
  • Silagen
  • Used/Demo systems
  • Surgical & Scar Prevention
  • LaserOptek
  • LASER SERVICE
  • Product
  • EVENTS

COVID-19

COVID-19 NEWS AND UPDATES

Learn about the Med-Aesthetics market experiencing astonishing economic recovery!


As the coronavirus spread across our country, our personal and professional lives have been impacted in unimaginable ways. Yet, amidst this, we are beginning to see glimmers of hope and optimism both in our country and in many other parts of the world. With these changes, comes hope. 2021 is setting records for AX industry growth.
 
 
We want to help you and your practice prepare for a healthy & safe resurgence, we are proudly offering unprecedented deals during these unprecedented times. With offers of not only incredibly low pricing and big discounts, low or no down payments and low monthly payments, but up to six months $99 payments (OAC)! We have a variety of offers for those who may be considering investing in growing their practice in energy-based devices!
Contact us about our specials or financing options.
 
Learn about cost saving, energy based devices repair and maintenance solutions here.

"THIS TOO SHALL PASS"

Find some helpful links from our partners below:

Picture
PictureRecorded webinar will be added when available!
Healeon Medical is committed to advancing science and therapeutics by providing support and resources to learn more about the various technologies and therapies that are resultant from their products. Healeon Medical's participation in sponsoring studies to help develop promising treatments and improve outcomes in a variety of applications is a large part of being a regenerative resource and one in which we take great pride in.

CURRENT STUDIES:
COVID-19 Treatment For Lung Complications

Healeon's safe and reliable CENTRIcyte 1000 system for isolating autologous stem cells is currently involved in several studies where intravenous administration of stem cells are administered to investigate treatment outcomes for COVID-19 patients, including one from our Chief Medical Officer, Dr. Robert Alexander, for lung complications associated with COVID-19. 


Here are the studies currently open or taking place regarding COVID-19:
​
https://clinicaltrials.gov/ct2/show/NCT04326036


https://clinicaltrials.gov/ct2/show/NCT04352803?term=Regeneris+medical&draw=2&rank=4


https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1761322




LEARN ABOUT CC1000
Proudly powered by Weebly
  • COVID-19 Info
  • Amnio2X
  • About
  • Contact Us
  • ENDYMED RF
  • HD-PRP
  • CC1000 Cell Isolation Platform
  • Aesthetic Rejuvenation
  • DermaSweep 2.0
  • Regenerative Medicine
  • Silagen
  • Used/Demo systems
  • Surgical & Scar Prevention
  • LaserOptek
  • LASER SERVICE
  • Product
  • EVENTS